Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Trice Medical reels in $12M, ex-Embrella founder O’Donnell
Trice Medical said it raised the 1st tranche of an $11.6 million Series B round and named medtech veteran Jeffrey O’Donnell Sr. as its new CEO.
Trice, which is developing a “micro-invasive” device called Mi-eye for outpatient diagnostic arthroscopy, said the round was led by a nearly $1.3 million contribution from Safeguard Scientifics that’s worth a 9.6% stake. BioStar Ventures and other prior backers also participated, according to a press release. Read more
2. Ex-Stryker CFO Hartman takes over at ConMed
Surgical device maker ConMed took a major hit on Wall Street today after announcing some turnover at the top and lowering its financial outlook for the rest of the year.
ConMed announced the retirement of founder Gene Corasanti and the resignation of CEO, president and director Joseph Corasanti, handing the corner office over to Curt Hartman, former CFO and interim CEO for Stryker, on an interim basis. Read more
1. FDA warns CareFusion over modified devices, quality control
CareFusion drew another warning letter from the FDA last month after an inspection last year revealed unapproved device changes and quality control process problems at a plant in Vernon Hills, Ill.
The June 6 letter asks CareFusion to “immediately cease activities that result in the misbranding or adulteration” of its anesthesia breathing circuit, the Denver ascites shunt and the Denver percutaneous access kit with ascites (peritoneovenous) shunt, including “the commercial distribution of these devices.” Read more